논문 목록
2건 · 최신순-
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity.
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin.…
-
Correction to the article "Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity", published on Acta Med Port 2020 Nov;33(11):761-764.
On page 761, in the first sentence of the Introduction, where it reads: "Cardiovascular Botulinum toxin A (BoNT-A) has beenapproved for spasticity management."It should read: "Botulinum toxin A (BoNT-A) has been approved for spasticity mana…